Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs
Oct 27, 2016
The US Centers for Disease Control and Prevention and the US Department of health and Human Services have been awarded US Patent No. 9,476,103, "Real-time PCR point mutation assays for detecting HIV-1 resistance to antiviral drugs."
This webinar will discuss how Amyris, a biotechnology company that develops renewable products for a broad range of applications and industries, uses large-scale microbial engineering to support its manufacturing processes.
This webinar will discuss how understanding the relative performance characteristics of glass and polymer substrates for in vitro diagnostic applications such as microarrays and microfluidics can help to optimize diagnostic performance.